Biotech company Argos raises $42.5 million in spite of tough market conditions

ArgosIn spite of the challenging climate to raise capital, a North Carolina biotech company raised $42.5 million for its kidney-focused cancer drug.

Stay connected with us on Twitter and LinkedIn. Article ideas and other suggestions should be sent to tballard@pyapc.com. Include the name and contact information (phone and email) for follow-up.